Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study
- PMID: 20016850
- PMCID: PMC2788700
- DOI: 10.1371/journal.pone.0008305
Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study
Abstract
Background: The clinical and financial outcomes of SSIs directly attributable to MRSA and methicillin-resistance are largely uncharacterized. Previously published data have provided conflicting conclusions.
Methodology: We conducted a multi-center matched outcomes study of 659 surgical patients. Patients with SSI due to MRSA were compared with two groups: matched uninfected control patients and patients with SSI due to MSSA. Four outcomes were analyzed for the 90-day period following diagnosis of the SSI: mortality, readmission, duration of hospitalization, and hospital charges. Attributable outcomes were determined by logistic and linear regression.
Principal findings: In total, 150 patients with SSI due to MRSA were compared to 231 uninfected controls and 128 patients with SSI due to MSSA. SSI due to MRSA was independently predictive of readmission within 90 days (OR = 35.0, 95% CI 17.3-70.7), death within 90 days (OR = 7.27, 95% CI 2.83-18.7), and led to 23 days (95% CI 19.7-26.3) of additional hospitalization and $61,681 (95% 23,352-100,011) of additional charges compared with uninfected controls. Methicillin-resistance was not independently associated with increased mortality (OR = 1.72, 95% CI 0.70-4.20) nor likelihood of readmission (OR = 0.43, 95% CI 0.21-0.89) but was associated with 5.5 days (95% CI 1.97-9.11) of additional hospitalization and $24,113 (95% 4,521-43,704) of additional charges.
Conclusions/significance: The attributable impact of S. aureus and methicillin-resistance on outcomes of surgical patients is substantial. Preventing a single case of SSI due to MRSA can save hospitals as much as $60,000.
Conflict of interest statement
Figures
Similar articles
-
Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost.Infect Control Hosp Epidemiol. 2004 Jun;25(6):461-7. doi: 10.1086/502422. Infect Control Hosp Epidemiol. 2004. PMID: 15242192
-
Adverse Clinical Outcomes and Resource Utilization Associated with Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Infections after Elective Surgery.Surg Infect (Larchmt). 2015 Oct;16(5):543-52. doi: 10.1089/sur.2013.250. Epub 2015 Jun 30. Surg Infect (Larchmt). 2015. PMID: 26125541
-
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.Clin Infect Dis. 2003 Mar 1;36(5):592-8. doi: 10.1086/367653. Epub 2003 Feb 7. Clin Infect Dis. 2003. PMID: 12594640
-
Burden of Surgical Site Infections Associated with Select Spine Operations and Involvement of Staphylococcus aureus.Surg Infect (Larchmt). 2017 May/Jun;18(4):461-473. doi: 10.1089/sur.2016.186. Epub 2016 Nov 30. Surg Infect (Larchmt). 2017. PMID: 27901415 Free PMC article. Review.
-
Methicillin-sensitive and methicillin-resistant Staphylococcus aureus: preventing surgical site infections following plastic surgery.Aesthet Surg J. 2009 May-Jun;29(3):232-44. doi: 10.1016/j.asj.2009.01.010. Aesthet Surg J. 2009. PMID: 19608074 Review.
Cited by
-
Fracture-related infection.Nat Rev Dis Primers. 2022 Oct 20;8(1):67. doi: 10.1038/s41572-022-00396-0. Nat Rev Dis Primers. 2022. PMID: 36266296 Review.
-
Cost effectiveness of temporary isolation rooms in acute care settings in Singapore.PLoS One. 2022 Jul 22;17(7):e0271739. doi: 10.1371/journal.pone.0271739. eCollection 2022. PLoS One. 2022. PMID: 35867648 Free PMC article.
-
Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice.Antimicrob Agents Chemother. 2012 May;56(5):2590-7. doi: 10.1128/AAC.06291-11. Epub 2012 Feb 27. Antimicrob Agents Chemother. 2012. PMID: 22371896 Free PMC article.
-
The impact of MRSA colonization on surgical site infection following major gastrointestinal surgery.J Gastrointest Surg. 2013 Jan;17(1):144-52; discussion p.152. doi: 10.1007/s11605-012-1995-2. Epub 2012 Sep 5. J Gastrointest Surg. 2013. PMID: 22948833
-
Incidence and Cost of Surgical Site Infections After Osteochondral Allograft Transplantation and Meniscal Allograft Transplantation in the Knee.Orthop J Sports Med. 2022 Mar 11;10(3):23259671221084701. doi: 10.1177/23259671221084701. eCollection 2022 Mar. Orthop J Sports Med. 2022. PMID: 35299714 Free PMC article.
References
-
- Cruse P. Wound infection surveillance. Rev Infect Dis. 1981;3:734–737. - PubMed
-
- Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am. 1980;60:27–40. - PubMed
-
- Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–730. - PubMed
-
- Scott RD. The direct medical costs of healthcare-associated Infections in U.S. hospitals and the benefits of prevention. 2009. Atlanta, GA: Division of Healthcare Quality Promotion National Center for Preparedness, Detection, and Control of Infectious Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention.
-
- Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:1047–1053. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical